1-7 of 7
immune checkpoint inhibitors
Close
Sort by
Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.
https://doi.org/10.1182/hematology.2019000032
Published: 2019
Journal Articles

Novel immunotherapy approaches to follicular lymphoma

Christopher R. Flowers, John P. Leonard, Loretta J. Nastoupil
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 194–199.
https://doi.org/10.1182/asheducation-2018.1.194
Published: 2018
Journal Articles

Risk-adapted therapy for advanced-stage Hodgkin lymphoma

Michael A. Spinner, Ranjana H. Advani
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 200–206.
https://doi.org/10.1182/asheducation-2018.1.200
Published: 2018
Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.
https://doi.org/10.1182/asheducation-2017.1.618
Published: 2017
Journal Articles

Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma

Craig Moskowitz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 331–338.
https://doi.org/10.1182/asheducation-2016.1.331
Published: 2016
Journal Articles

Checkpoint inhibition in myeloma

Don M. Benson, Jr
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 528–533.
https://doi.org/10.1182/asheducation-2016.1.528
Published: 2016
Journal Articles

Therapeutic targeting of microenvironment in follicular lymphoma

Grzegorz S. Nowakowski, Stephen M. Ansell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 169–173.
https://doi.org/10.1182/asheducation-2014.1.169
Published: 2014